Naoko Namiki

Title: Naoko Namiki: Innovator in Humanized Antibodies

Introduction

Naoko Namiki is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. With a total of five patents to her name, her work focuses on innovative solutions for medical challenges.

Latest Patents

One of her latest patents is an anti-IGF-I receptor humanized antibody. This invention provides a humanized antibody that increases muscle mass without lowering blood glucose levels through the IGF-I receptor. The antibody is characterized by a specific amino acid sequence, including CDR sequences, that specifically binds to the extracellular domain of the IGF-I receptor. Another notable patent involves a humanized antibody for treating or preventing cognitive disorders. This invention outlines methods and compositions of humanized antibodies that target tau protein phosphorylated at serine position 413.

Career Highlights

Throughout her career, Naoko Namiki has worked with esteemed companies such as Teijin Pharma Limited and Merck Sharp & Dohme Corporation. Her experience in these organizations has allowed her to advance her research and contribute to significant medical innovations.

Collaborations

Naoko has collaborated with notable colleagues, including Hiroshi H. Eguchi and Akira Tanokura. These partnerships have further enriched her research and development efforts in the field of biotechnology.

Conclusion

Naoko Namiki's work in the development of humanized antibodies showcases her innovative spirit and dedication to advancing medical science. Her contributions are paving the way for new treatments and therapies that can significantly impact patient care.